About Five Liters
Five Liters is a Healthcare company based in Dallas (United States) founded in 2022. Developer of medical device for non-invasive neuromodulation of hemorrhaging. Five Liters has raised $500 thousand across 1 funding round from investors including Pathway to Cures. Five Liters offers products and services including tAN Device and Neural Tourniquet. Its focus areas include Life Sciences, Hematology, Medical Devices and Therapeutic. Its legal entity is Spark Biomedical, Inc. Its competitors include Route 92 Medical, Haemonetics and Autonomix; 2 of its 3 listed competitors have raised funding.
Company details
Five Liters developer of medical device for non-invasive neuromodulation of hemorrhaging, focusing on life sciences, hematology, developing medical devices, and therapeutic. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Dallas, United States
- SectorsHealthcare
- Website fiveliters.com
- Social LinkedIn
- Legal Name Spark Biomedical, Inc.
- Total Equity Funding$500K (USD)
in 1 rounds
- Latest Funding Round$500K (USD), Seed
Oct 2023
- Investors
Products & Services of Five Liters
Five Liters offers a comprehensive portfolio of products and services, including tAN Device and Neural Tourniquet.
Non-invasive tool for reducing blood loss via nerve stimulation.
System that enhances clotting in injuries using vagus nerve stimulation.
Funding Insights of Five Liters
Five Liters has successfully raised a total of $500K through 1 strategic funding round. The most recent funding activity was a Seed round of $500 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $500,000
- Total Rounds 1
- Last Round Seed — $500,000
- First Round $500,000
(Oct 2023)
- Investors Count 1
All 1 funding rounds of Five Liters with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $500,000 | Seed | – | Pathwaytocures | – |
1 investors in total: 1 institutional.
Investors in Five Liters
Five Liters has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Pathway to Cures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pathway to Cures is focused on funding therapies for inheritable blood disorders. | pathwaytocures.org | New York, United States |
Investor details for Five Liters
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Five Liters
2 dated milestones of Five Liters across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Five Liters is founded.
- Funding First funding round of $500K.
Competitors of Five Liters
Five Liters has 3 listed competitors in our database, 2 of them funded. They include Route 92 Medical, Haemonetics and Autonomix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| route92medical.com | 2015 | San Mateo, United States | $167.15M | 51 | Next-generation products for neurointerventional procedures are developed. | |
| haemonetics.com | 1971 | Braintree, United States | 3,034 | Hematology products and solutions are provided for medical applications. | ||
| autonomix.com | 2014 | The Woodlands, United States | $8.2M | Minimally invasive neural monitoring and treatment devices are developed. |
Detailed competitors of Five Liters
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
3 companies that operate in the same segment as Five Liters (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Five Liters
Five Liters was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Five Liters is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Five Liters is a funded company, having raised a total of $500K across 1 funding round to date. The company's 1st funding round was a Seed of $500K, raised on Oct 2023.
Five Liters developer of medical device for non-invasive neuromodulation of hemorrhaging, focusing on life sciences, hematology, developing medical devices, and therapeutic. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Five Liters's top competitors include Route 92 Medical, Haemonetics and Autonomix.
Five Liters offers tAN Device and Neural Tourniquet.
Five Liters has 1 investor. Key investors include Pathway to Cures.
Five Liters operates through Spark Biomedical, Inc..